Hood River Capital Management »

Blueprint Medicines shares owned by Hood River Capital Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Hood River Capital Management from 13F filings

Historical chart of Hood River Capital Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Hood River Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Hood River Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $14M 274k 50.22
2023-06-30 $17M 273k 63.20

More positions owned by Hood River Capital Management

Ftai Aviation Common Stocks (FTAI)
Rambus Common Stocks (RMBS)
Lantheus Holdings Common Stocks (LNTH)
Celsius Holdings Common Stocks (CELH)
Comfort Systems Usa Common Stocks (FIX)
Onto Innovation Common Stocks (ONTO)
Firstcash Holdings Common Stocks (FCFS)
Axonics Common Stocks (AXNX)
Clean Harbors Common Stocks (CLH)
Vertiv Holdings Common Stocks (VRT)
Kinsale Capital Group Common Stocks (KNSL)
Kirby Corp Common Stocks (KEX)
Axcelis Technologies Common Stocks (ACLS)
Select Medical Holdings Corp Common Stocks (SEM)
Krystal Biotech Common Stocks (KRYS)

View all positions for Hood River Capital Management

Top funds holding Blueprint Medicines

BlackRock
Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Alliancebernstein
Lord, Abbett & Co
Jpmorgan Chase & Co
Brown Advisory Holdings Incorporated
Susquehanna International
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Point72 Asset Management

View all funds holding Blueprint Medicines